Publicaciones RedinRen

• Effect of cicletanine on renal cGMP production.

  Valdivielso JM, Morales AI, Pérez-Barriocanal F, López-Novoa JM. Can J Physiol Pharmacol. 1998 Dec;76(12):1151-5.

• 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter.

  Cardus A, Panizo S, Encinas M, Dolcet X, Gallego C, Aldea M. Atherosclerosis. 2009 May;204(1):85-9.

• Endothelin-converting enzyme-1 increases in atherosclerotic mice: potential role of oxidized low density lipoproteins.

  Martínez-Miguel P, Raoch V, Zaragoza C, Valdivielso JM, Rodríguez-Puyol M, Rodríguez-Puyol D. J Lipid Res. 2009 Mar;50(3):364-75.

• Vitamin D and the vasculature: can we teach an old drug new tricks?

  Valdivielso JM, Coll B, Fernandez E. Expert Opin Ther Targets. 2009 Jan;13(1):29-38.

• RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.

  Panizo S, Cardus A, Encinas M, Parisi E, Valcheva P, López-Ongil S. Circ Res. 2009 May 8;104(9):1041-8.

• N-methyl-D-aspartate receptors are expressed in rat parathyroid gland and regulate PTH secretion.

  Parisi E, Almadén Y, Ibarz M, Panizo S, Cardús A, Rodriguez M. Am J Physiol Renal Physiol. 2009 Jun;296(6):F1291-6.

• Occult chronic kidney disease: discordance among different methods used to estimate glomerular filtration rate in a healthy population.

  Marco MP, Muray S, Valdivielso JM, Fernández E. Clin Nephrol. 2009 May;71(5):475-81.

• The physiology of vitamin D receptor activation.

  Valdivielso JM. Contrib Nephrol. 2009;163:206-12.

• A new role for vitamin D receptor activation in chronic kidney disease.

  Valdivielso JM, Cannata-Andía J, Coll B, Fernández E. Am J Physiol Renal Physiol. 2009 Dec;297(6):F1502-9.

• [Usefulness of imaging techniques and novel biomarkers in the prediction of cardiovascular risk in patients with chronic kidney disease in Spain: the NEFRONA project].

  Junyent M, Martínez M, Borrás M, Bertriu A, Coll B, Craver L. Nefrologia. 2010;30(1):119-26.

• Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: usefulness of non-invasive tests in cardiovascular assessment.

  Coll B, Betriu A, Martínez-Alonso M, Borràs M, Craver L, Amoedo ML. Nephrol Dial Transplant. 2010 Sep;25(9):3017-25.

• Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy.

  Sanchez-Niño MD, Sanz AB, Carrasco S, Saleem MA, Mathieson PW, Valdivielso JM. Nephrol Dial Transplant. 2011 Jun;26(6):1797-802.

• Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study.

  Junyent M, Martínez M, Borràs M, Coll B, Valdivielso JM, Vidal T. BMC Nephrol. 2010 Jul 7;11:14.

• Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT.

  Parisi E, Bozic M, Ibarz M, Panizo S, Valcheva P, Coll B. Am J Physiol Endocrinol Metab. 2010 Nov;299(5):E825-31.

• Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease.

  Coll B, Rodríguez JA, Craver L, Orbe J, Martínez-Alonso M, Ortiz A. Kidney Int. 2010 Dec;78(12):1275-80.

• Large artery calcification on dialysis patients is located in the intima and related to atherosclerosis.

  Coll B, Betriu A, Martínez-Alonso M, Amoedo ML, Arcidiacono MV, Borras M. Clin J Am Soc Nephrol. 2011 Feb;6(2):303-10.

• [Vascular calcification: types and mechanisms].

  Valdivielso JM. Nefrologia. 2011;31(2):142-7.

• Glutamatergic signaling maintains the epithelial phenotype of proximal tubular cells.

  Bozic M, de Rooij J, Parisi E, Ortega MR, Fernandez E, Valdivielso JM. J Am Soc Nephrol. 2011 Jun;22(6):1099-111.

• Calcium signaling in renal tubular cells.

  Bozic M, Valdivielso JM. Adv Exp Med Biol. 2012;740:933-44.

• Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumorigenesis.

  Macià A, Vaquero M, Gou-Fàbregas M, Castelblanco E, Valdivielso JM, Anerillas C. Cell Death Differ. 2014 Feb;21(2):333-43.

• Lack of vitamin D receptor causes stress-induced premature senescence in vascular smooth muscle cells through enhanced local angiotensin-II signals.

  Valcheva P, Cardus A, Panizo S, Parisi E, Bozic M, Lopez Novoa JM. Atherosclerosis. 2014 Aug;235(2):247-55.

• High phosphate diet increases arterial blood pressure via a parathyroid hormone mediated increase of renin.

  Bozic M, Panizo S, Sevilla MA, Riera M, Soler MJ, Pascual J. J Hypertens. 2014 Sep;32(9):1822-32.

• Assessment of the potential role of active vitamin D treatment in telomere length: a case-control study in hemodialysis patients.

  Borras M, Panizo S, Sarró F, Valdivielso JM, Fernandez E. Clin Ther. 2012 Apr;34(4):849-56.

• Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease.

  Valdivielso JM, Coll B, Martín-Ventura JL, Moreno JA, Egido J, Fernández E. J Nephrol. 2013 Nov-Dec;26(6):1105-13.

• Microangiopathy of large artery wall: a neglected complication of diabetes mellitus.

  Arcidiacono MV, Traveset A, Rubinat E, Ortega E, Betriu A, Hernández M. Atherosclerosis. 2013 May;228(1):142-7.

• N-terminal pro-brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation.

  Purroy F, Suárez-Luis I, Mauri-Capdevila G, Cambray S, Farré J, Sanahuja J. Eur J Neurol. 2014 Apr;21(4):679-83.

• Pseudo-enhancement does not explain the increased carotid adventitial vasa vasorum signal in diabetic patients.

  Arcidiacono MV, Rubinat E, Ortega E, Betriu A, Fernández E, Mauricio D. Atherosclerosis. 2013 Aug;229(2):459-61.

• A low fractional excretion of Phosphate/Fgf23 ratio is associated with severe abdominal Aortic calcification in stage 3 and 4 kidney disease patients.

  Craver L, Dusso A, Martinez-Alonso M, Sarro F, Valdivielso JM, Fernández E. BMC Nephrol. 2013 Oct 12;14:221.

• The Role of Carotid Ultrasound in Assessing Carotid Atherosclerosis in Individuals at Low-to-intermediate Cardiovascular Risk.

  Coll B, Betriu A, Feinstein SB, Valdivielso JM, Zamorano JL, Fernández E. Rev Esp Cardiol. 2013 Dec;66(12):929-934.

• Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma.

  Bergadà L, Pallares J, Vittoria Arcidiacono M, Cardus A, Santacana M, Valls J. Lab Invest. 2014 Jun;94(6):608-22.

• The Role of Carotid Ultrasound in Assessing Carotid Atherosclerosis in Individuals at Low-to-intermediate Cardiovascular Risk.

  Coll B, Betriu A, Feinstein SB, Valdivielso JM, Zamorano JL, Fernández E. Rev Esp Cardiol (Engl Ed). 2013 Dec;66(12):929-34.

• Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study.

  Betriu A, Martinez-Alonso M, Arcidiacono MV, Cannata-Andia J, Pascual J, Valdivielso JM. Nephrol Dial Transplant. 2014 Feb 28;.

• Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.

  Sanchez-Niño MD, Bozic M, Córdoba-Lanús E, Valcheva P, Gracia O, Ibarz M. Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F647-57.